PFE and BMY Related Headlines

Go Back

Mar 14, 2014 01:04PM Bristol-Myers (BMY), Pfizer (PFE) Report FDA Approval of Eliquis sNDA
Jan 13, 2014 08:17AM Portola Pharmaceuticals (PTLA) Enters Second Collaboration Deal with Bristol-Myers (BMY)
Dec 19, 2013 05:02PM Bristol-Myers (BMY), Pfizer (PFE) sNDA for ELIQUIS Approved by FDA
Aug 30, 2013 02:29PM Drug Companies on Watch Heading Into ESC Meeting; Goldman Comments (JNJ) (BMY) (PFE)
Aug 13, 2013 03:23PM Novartis (NVS), Pfizer (PFE) Out on Onyx (ONXX); Is Amgen (AMGN) the Sole Runner?
Jul 18, 2013 03:29PM Pfizer (PFE) Won't Move Ahead With Bid for Onyx (ONXX); Amgen (AMGN) Now in Lead
Jul 11, 2013 07:31AM Bristol-Myers (BMY), Pfizer (PFE) Repor FDA Acceptance of Eliquis sNDA
Jun 17, 2013 01:08PM Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)

PFE and BMY Related Press Releases

Go Back

Mar 27, 2014 08:14AM In A Subanalysis, The Benefits Of Eliquis® (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure Contro
Mar 14, 2014 01:00PM U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery
Feb 21, 2014 11:06AM In a Subanalysis, Eliquis® (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular
Jan 13, 2014 08:00AM Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With

PFE and BMY Related SEC Filings

Go Back